Remodeling of the Tumor Microenvironment Through PAK4 Inhibition Sensitizes Tumors to Immune Checkpoint Blockade | Citedby Results | Cancer Research Communications | American Association for Cancer Research

Skip to Main Content

Skip Nav Destination

Remodeling of the Tumor Microenvironment Through PAK4 Inhibition Sensitizes Tumors to Immune Checkpoint Blockade

Cancer Research Communications (2022) 2 (10): 1214–1228.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Inhibition of P21-activated kinases 1 and 4 synergistically suppresses the growth of pancreatic cancer by stimulating anti-tumour immunity

Yi Ma
Chelsea Dumesny
Li Dong
Ching-Seng Ang
Khashayar Asadi
Yifan Zhan
Mehrdad Nikfarjam
Hong He

Cell Communication and Signaling (2024) 22 (1)

Development of a PAK4-targeting PROTAC for renal carcinoma therapy: concurrent inhibition of cancer cell proliferation and enhancement of immune cell response

Shan Xu
Bohan Ma
Yanlin Jian
Chen Yao
Zixi Wang
Yizeng Fan
Jian Ma
Yule Chen
Xiaoyu Feng
Jiale An
Jiani Chen
Ke Wang
Hongjun Xie
Yang Gao
Lei Li

eBioMedicine (2024) 104: 105162.

PAK in Pancreatic Cancer-Associated Vasculature: Implications for Therapeutic Response

Arian Ansardamavandi
Mehrdad Nikfarjam
Hong He

Cells (2023) 12 (23): 2692.

Expression Patterns of PAK4 and PHF8 Are Associated with the Survival of Gallbladder Carcinoma Patients

Ae Ri Ahn
Maryam Karamikheirabad
Min Su Park
Junyue Zhang
Hyun Sun Kim
Ji Su Jeong
Kyoung Min Kim
Ho Sung Park
Kyu Yun Jang

Diagnostics (2023) 13 (6): 1149.